Keyword Search
PRESS RELEASE
Nov 06, 2025
Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update
PRESS RELEASE
Oct 30, 2025
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
PRESS RELEASE
Oct 28, 2025
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
PRESS RELEASE
Oct 23, 2025
Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time
PRESS RELEASE
Sep 24, 2025
Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan
PRESS RELEASE
Sep 02, 2025
Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
PRESS RELEASE
Aug 06, 2025